Digital Mental Healthcare
Sign up today and learn more about Mindstrong Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Mindstrong Stock
Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.
Chief Executive Officer
Chief Technology Officer